fda tirzepatide injection shortage resolved oct 2 2024 october Eli Lilly's is off the FDA's drug list: Here's what it means Drugmakers and pharmacists battle over – What is the latest update

Linagliptin is protective for both macrovascular and microvascular complications of diabetes in preclinical models, as well as clinical models

Evaluate any review data you encounter on third-party platforms critically and independently

It's important to note that GLP-1 receptor agonists for weight management should not be used during pregnancy and are not recommended during breastfeeding

The proportion of patients who were White ranged from 48% to 86%, Black ranged from 3% to 8%, Asian ranged from 7% to 36%, and Hispanic or Latino ranged from 4% to 30% in the rest of the PIONEER trials

This article is for educational purposes and does not constitute medical advice

Additionally, visceral adiposity promotes systemic inflammation and metabolic dysfunction that may further compromise upper airway neuromuscular control